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SHORT COMMUNICATION
Abstract: Hemoglobinopathies are important inherited disorders with high prevalence in
many tropical countries. Prediction of protein nanostructure and function is a great challenge
in proteomics and structural genomics. Identifying the point vulnerable to mutation is a new
trend in research on disorders at the genomic and proteomic level. A bioinformatics analysis
was performed to determine the positions that tend to correspond with peptide motifs in the
amino acid sequence of alpha and beta globin chains. To identify the weak linkage in alpha
globin and beta globin chains, a new bioinformatics tool, GlobPlot, was used. For the alpha
globin chain, 22 positions were identified: the disorders were found at positions 3–8, 38–42,
46–51, and 75–79. For the beta globin chain, 46 positions were identified: the disorders were
found at positions 61–146. The study showed that weak linkages in alpha globin and beta
globin chains can be identified and provide good information for predicting possible new
mutations that could lead to new hemoglobinopathies.
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Introduction
Hemoglobinopathies are important inherited disorders with high prevalence in many
tropical countries (Atweh et al 2003). In structurally abnormal hemoglobins, the
following mechanisms can be invoked: single nucleotide base substitutions leading
to amino acid replacement or chain termination variants; nucleotide deletions (or
additions) leading to deletion and frameshift variants; and nonhomologous crossing
over leading to the production of fused globin chains (Forget 1979). A defect in the
globin chain is the main cause of hemoglobinopathies. The molecular basis of the
hemoglobinopathies, disorders characterized by the absence of, or decreased, synthesis
of alpha globin or beta globin chains, is quite heterogeneous (Forget 1979). The
mutation in the gene coding for alpha globin or beta globin chains is the underlying
pathogenesis of hemoglobinopathies (Atweh et al 2003). Clinical manifestations of
these disorders vary from mild to severe presentations (Atweh et al 2003).
Predicting protein nanostructure and function is a great challenge in proteomics
and structural genomics. Identifying the point vulnerable to mutation is a new trend
in research on disorders at the genomic and proteomic level (Levin et al 2002; Lee
and Wang 2005). Generally, disordered regions in proteins often contain short linear
peptide motifs that are important for protein function. Identification of the peptide
motifs in the amino acid sequence can give a good prediction of the weak linkages in
a protein (Levin et al 2002; Lee and Wang 2005). A bioinformatics analysis was
peformed to determine positions that tend to correspond with peptide motifs in the
amino acid sequence of alpha globin and beta globin chains.
Materials and methods
Obtaining the amino acid sequence
The database ExPASy (Gasteiger et al 2003) was used for searching the amino acid
sequence of normal human alpha globin and beta globin chains. The derived sequences
were then used to identify the weak linkage.
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Identification of weak linkage in the
globin chains
To identify the weak linkage in alpha globin and beta globin
chains, a new bioinformatics tool, GlobPlot (Linding et al
2003), was used. GlobPlot is a web service that allows the
user to plot the tendency within the query protein for order/
globularity and disorder (Linding et al 2003). It successfully
identifies interdomain segments containing linear motifs,
and also apparently ordered regions that do not contain any
recognized domains (Linding et al 2003).
Results
Twenty-two positions were identified for the alpha globin
chain (Figure 1). The disorders were found at positions 3–
8, 38–42, 46–51, and 75-79. Forty-six positions were
identified for the beta globin chain (Figure 2). The disorders
were found at positions 61–146.
Discussion
Structural aberration is believed to be the main underlying
pathogenesis in hemoglobinopathy (Atweh et al 2003).
Some disorders are described as a single substitution with
other effects on the sequence frame; other disorders are
mentioned as a frameshift (Atweh et al 2003). The mutations
in globins can bring clinical manifestation in affected
subjects. There are many reported mutations of globin and
there are many undetermined ones. In the present study, an
algorithm was used to identify the positions in the amino
acid sequences of alpha globin and beta globin chains that
can mutate.
Many positions were identified; some are known and
others are newly discovered. Of interest, fewer positions
were identified in alpha globin than in beta globin. More
points with known mutations have been reported for beta
globin than for alpha globin (Atweh et al 2003). The present
study shows that weak linkages in the alpha globin and beta
globin chains can be identified and can provide good
information for predicting possible new mutations that can
lead to new hemoglobin disorders.
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mvLSPADKtn vkaawgkvga hageygaeal ekmflsfPTT
KTyfpHFDLS Hgsaqvkghg kkvadaltna vahvDDMPNa
lsalsdlhah klrvdpvnfk llshcllvtl aahlpaeftp avhasldkfl
asvstvltsk yr
Figure 1 Identified positions (in capitals) that correspond with peptide motifs
in amino acid sequence of alpha globin.
vhltpeeksa vtalwgkvnv devggealgr llvvypwtqr ffesfgdlst
pdavmgnpkv KAHGKKVLGA FSDGLAHLDN
LKGTFATLSE LHCDKLHVDP ENFRLLGNVL
VCVLAHHFGK EFTPPVQAAY QKVVAGVANA
LAHKYH
Figure 2 Identified positions (in capitals) that correspond with peptide motifs
in amino acid sequence of beta globin.